Association between tumor necrosis factor inhibitor (TNFi) therapy and changes in C-reactive protein (CRP), blood pressure, and alanine aminotransferase (ALT) among patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis.

Wu, Jashin J; Rowan, Christopher G; Bebchuk, Judith D; Anthony, Mary S

Wu, Jashin J; Rowan, Christopher G; Bebchuk, Judith D; Anthony, Mary S.

Affiliation

Wu JJ; Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, California. Electronic address: jashinwu@hotmail.com.
Rowan CG; American Medical Group Association, Alexandria, Virginia.
Bebchuk JD; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California.
Anthony MS; Amgen, Center for Observational Research, Thousand Oaks, California.

J Am Acad Dermatol ; 72(5): 917-9, 2015 May.

Article in En | MEDLINE | ID: mdl-25748312

Subject(s)

Alanine Transaminase/blood; Arthritis, Psoriatic/drug therapy; Arthritis, Rheumatoid/drug therapy; Blood Pressure/drug effects; C-Reactive Protein/analysis; Psoriasis/drug therapy; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Arthritis, Psoriatic/blood; Arthritis, Rheumatoid/blood; Cohort Studies; Humans; Methotrexate/therapeutic use; Middle Aged; Psoriasis/blood; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Psoriasis / Blood Pressure / C-Reactive Protein / Arthritis, Psoriatic / Tumor Necrosis Factor-alpha / Alanine Transaminase Type of study: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google